PDUFA Date
VERA: FDA Decision: trutakna
July 7, 2026 · trutakna · approval. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- July 7, 2026
- Company
- Vera Therapeutics, Inc. (VERA)
- Drug
- trutakna
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
PDUFA Dateapproval
FDA Decision: trutakna
- Drug
- trutakna
- Indication
- 1 INDICATIONS AND USAGE TRUTAKNA is indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. This indication is approved under accelerated approval based on reduction of proteinuria. It has not been established whether TRUTAKNA slows kidney function decline over the long-term in patients with IgAN. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory clin